-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Gyre Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2013 to 2023.
- Gyre Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $16K, a 82% decline year-over-year.
- Gyre Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $7.01M, a 45.3% decline year-over-year.
- Gyre Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $7.28M, a 45.5% decline from 2022.
- Gyre Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $13.4M, a 293% increase from 2021.
- Gyre Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $3.41M, a 6.12% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)